Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Nearing Retirement? These Stocks Will Pay You For Life


While government programs help retirees replace some of their income once they stop working, these initiatives aren't meant to fund all of people's expenses in their golden years. That's why many retirees seek additional income. One place to look is the stock market. Investing in reliable dividend stocks can be a great source of steady passive income, but only if the stocks in question have the tools to distribute growing payouts for a while.

Let's look at two companies that can do that: (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD).

AbbVie is well-known among dividend investors thanks to its solid business, strong prospects, and excellent dividend profile. Let's start with the company's business. AbbVie markets a range of drugs across several therapeutic areas, although its top field of expertise is arguably immunology. The company recently lost U.S. patent protection for its blockbuster therapy Humira. That's why AbbVie's sales have been declining and why it has performed poorly on the stock market since January.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€175.02
-0.470%
AbbVie Inc. shows a slight decrease today, losing -€0.820 (-0.470%) compared to yesterday.
The stock is an absolute favorite of our community with 31 Buy predictions and no Sell predictions.
As a result the target price of 180 € shows a slightly positive potential of 2.85% compared to the current price of 175.02 € for AbbVie Inc..
Like: 0
Share

Comments